Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 May 1.

Published in final edited form as: Cell Mol Neurobiol. 2020 Nov 17;42(4):1141–1152. doi: 10.1007/s10571-020-01005-y

Figure 1. — Pressor effects (Fig. 1A and 1B) and heart rate (HR) (Fig. 1C and 1D) changes induced by angiotensin (ANG) II in control, coyote urine scent exposed, and coyote urine scent exposed plus pretreatment plus either captopril (Cap) or pentoxifylline (PTX) rats. The enhanced pressor effect in coyote urine scent exposed rats was attenuated by either Cap or PTX pretreatment. Baseline recordings are denoted by B’s. (n=7–10/group; * p<0.05 vs baseline; # p<0.05 vs control or coyote urine scent exposed rats plus Cap or PTX pretreatment; ǂ p<0.05 vs coyote urine scent exposed or coyote urine scent exposed rats with PTX pretreatment; § p<0.05 vs control, coyote urine scent exposed or coyote urine scent exposed rats with PTX pretreatment).

Figure 1. — Pressor effects (Fig. 1A and 1B) and heart rate (HR) (Fig. 1C and 1D) changes induced by angiotensin (ANG) II in control, coyote urine scent exposed, and coyote urine scent exposed plus pretreatment plus either captopril (Cap) or pentoxifylline (PTX) rats. The enhanced pressor effect in coyote urine scent exposed rats was attenuated by either Cap or PTX pretreatment. Baseline recordings are denoted by B’s. (n=7–10/group; * p<0.05 vs baseline; # p<0.05 vs control or coyote urine scent exposed rats plus Cap or PTX pretreatment; ǂ p<0.05 vs coyote urine scent exposed or coyote urine scent exposed rats with PTX pretreatment; § p<0.05 vs control, coyote urine scent exposed or coyote urine scent exposed rats with PTX pretreatment).